NSAID use and risk of Parkinson disease: a population‐based case‐control study
Identifieur interne : 000233 ( Main/Exploration ); précédent : 000232; suivant : 000234NSAID use and risk of Parkinson disease: a population‐based case‐control study
Auteurs : C. Becker [Suisse] ; S. S. Jick [États-Unis] ; C. R. Meier [Suisse, États-Unis]Source :
- European Journal of Neurology [ 1351-5101 ] ; 2011-11.
English descriptors
- KwdEn :
Abstract
Background: Previous epidemiologic studies have produced inconsistent findings regarding the association between the use of non‐steroidal anti‐inflammatory drugs (NSAIDs) and the risk of Parkinson disease (PD). Methods: We conducted a case–control analysis using the General Practice Research Database. Cases (≥40 years) had a new diagnosis of PD between 1994 and 2009. We matched four controls to each PD case on age, sex, general practice, and index date. Use of NSAIDs, aspirin, and acetaminophen was stratified by exposure timing and duration for both cases and controls. We calculated odds ratios (OR) using conditional logistic regression. For additional analyses, the index date was brought backward 1, 2, and 3 years, respectively. Results: We identified 4026 cases with an incident idiopathic PD diagnosis and 15 969 matched controls. Compared with patients without any previous prescription for NSAIDs, those with prior use had no increased risk of a PD diagnosis (OR 1.07, 95% CI 0.99–1.16). Long‐term use (≥15 prescriptions) was associated with a slightly lower PD risk (adjusted OR 0.94, 95% CI 0.83–1.07). The relative PD risks of the use of aspirin or acetaminophen were not materially higher (PD risk of long‐term use: adjusted ORs 1.16, 95% CI 1.03–1.30 and 1.15, 95% CI 1.02–1.30, respectively) compared with those for non‐users. The risk estimate diminished toward the null in subsequent analyses with shifted index dates. Conclusion: In this large observational study with data from the UK primary care, the long‐term use of NSAIDs, aspirin, or acetaminophen was not associated with a substantially altered risk of developing PD.
Url:
DOI: 10.1111/j.1468-1331.2011.03399.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">NSAID use and risk of Parkinson disease: a population‐based case‐control study</title><author><name sortKey="Becker, C" sort="Becker, C" uniqKey="Becker C" first="C." last="Becker">C. Becker</name></author><author><name sortKey="Jick, S S" sort="Jick, S S" uniqKey="Jick S" first="S. S." last="Jick">S. S. Jick</name></author><author><name sortKey="Meier, C R" sort="Meier, C R" uniqKey="Meier C" first="C. R." last="Meier">C. R. Meier</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:2DA69C60955AB3398C85649A97FE5725EE5A60D0</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1111/j.1468-1331.2011.03399.x</idno><idno type="url">https://api.istex.fr/document/2DA69C60955AB3398C85649A97FE5725EE5A60D0/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000086</idno><idno type="wicri:Area/Main/Curation">000069</idno><idno type="wicri:Area/Main/Exploration">000233</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">NSAID use and risk of Parkinson disease: a population‐based case‐control study</title><author><name sortKey="Becker, C" sort="Becker, C" uniqKey="Becker C" first="C." last="Becker">C. Becker</name><affiliation wicri:level="1"><country xml:lang="fr">Suisse</country><wicri:regionArea>Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel</wicri:regionArea><wicri:noRegion>University of Basel</wicri:noRegion></affiliation></author><author><name sortKey="Jick, S S" sort="Jick, S S" uniqKey="Jick S" first="S. S." last="Jick">S. S. Jick</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Meier, C R" sort="Meier, C R" uniqKey="Meier C" first="C. R." last="Meier">C. R. Meier</name><affiliation wicri:level="1"><country xml:lang="fr">Suisse</country><wicri:regionArea>Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel</wicri:regionArea><wicri:noRegion>University of Basel</wicri:noRegion></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Suisse</country><wicri:regionArea>Hospital Pharmacy, University Hospital, Spitalstrasse 26, Basel</wicri:regionArea><wicri:noRegion>Basel</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Neurology</title><idno type="ISSN">1351-5101</idno><idno type="eISSN">1468-1331</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2011-11">2011-11</date><biblScope unit="volume">18</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1336">1336</biblScope><biblScope unit="page" to="1342">1342</biblScope></imprint><idno type="ISSN">1351-5101</idno></series><idno type="istex">2DA69C60955AB3398C85649A97FE5725EE5A60D0</idno><idno type="DOI">10.1111/j.1468-1331.2011.03399.x</idno><idno type="ArticleID">ENE3399</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1351-5101</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson disease</term><term>case–control analysis</term><term>epidemiology</term><term>non‐steroidal anti‐inflammatory drugs</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: Previous epidemiologic studies have produced inconsistent findings regarding the association between the use of non‐steroidal anti‐inflammatory drugs (NSAIDs) and the risk of Parkinson disease (PD). Methods: We conducted a case–control analysis using the General Practice Research Database. Cases (≥40 years) had a new diagnosis of PD between 1994 and 2009. We matched four controls to each PD case on age, sex, general practice, and index date. Use of NSAIDs, aspirin, and acetaminophen was stratified by exposure timing and duration for both cases and controls. We calculated odds ratios (OR) using conditional logistic regression. For additional analyses, the index date was brought backward 1, 2, and 3 years, respectively. Results: We identified 4026 cases with an incident idiopathic PD diagnosis and 15 969 matched controls. Compared with patients without any previous prescription for NSAIDs, those with prior use had no increased risk of a PD diagnosis (OR 1.07, 95% CI 0.99–1.16). Long‐term use (≥15 prescriptions) was associated with a slightly lower PD risk (adjusted OR 0.94, 95% CI 0.83–1.07). The relative PD risks of the use of aspirin or acetaminophen were not materially higher (PD risk of long‐term use: adjusted ORs 1.16, 95% CI 1.03–1.30 and 1.15, 95% CI 1.02–1.30, respectively) compared with those for non‐users. The risk estimate diminished toward the null in subsequent analyses with shifted index dates. Conclusion: In this large observational study with data from the UK primary care, the long‐term use of NSAIDs, aspirin, or acetaminophen was not associated with a substantially altered risk of developing PD.</div></front></TEI><affiliations><list><country><li>Suisse</li><li>États-Unis</li></country><region><li>Massachusetts</li></region></list><tree><country name="Suisse"><noRegion><name sortKey="Becker, C" sort="Becker, C" uniqKey="Becker C" first="C." last="Becker">C. Becker</name></noRegion><name sortKey="Meier, C R" sort="Meier, C R" uniqKey="Meier C" first="C. R." last="Meier">C. R. Meier</name><name sortKey="Meier, C R" sort="Meier, C R" uniqKey="Meier C" first="C. R." last="Meier">C. R. Meier</name></country><country name="États-Unis"><region name="Massachusetts"><name sortKey="Jick, S S" sort="Jick, S S" uniqKey="Jick S" first="S. S." last="Jick">S. S. Jick</name></region><name sortKey="Meier, C R" sort="Meier, C R" uniqKey="Meier C" first="C. R." last="Meier">C. R. Meier</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000233 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000233 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:2DA69C60955AB3398C85649A97FE5725EE5A60D0
|texte= NSAID use and risk of Parkinson disease: a population‐based case‐control study
}}
| This area was generated with Dilib version V0.6.23. |  |